Niki BioSolutions, Inc. (NIKI)
Nasdaq: NIKI · Measuring & Controlling Devices, NEC · London, GB · filing with the SEC since 2018
Who owns Niki BioSolutions, Inc.
As filed with the SECHolders of 5% or more
1
Kira S. Sheinerman holds 51.6% of Common Stock, par value $0.0001, as its SCHEDULE 13D filed Jul 24, 2026 says.
Directors and officers
5
report now, of 5 people on the record since 2026. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 1 named at left.
Holders of 5% or moreshare of the class, as filed
Kira S. Sheinerman
SCHEDULE 13D · filed Jul 24, 2026 · Common Stock, par value $0.0001
L1 Capital Global Opportunities Master Fund, Ltd.
SCHEDULE 13G/A · filed May 15, 2025 · Class A Ordinary Shares, par value $0.00001 per share · reported falling below 5%, from 7.2% in Jan 6, 2025
Scoggin International Fund Ltd.
SCHEDULE 13G · filed Jan 10, 2025 · Class A Ordinary Shares, par value $0.00001 per share · reported falling below 5%
What NIKI reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
Scipio
An investee · consolidated entity, investee, related party · invested in, named in the 20-F filed Mar 27, 2026
Insider tradesForm 4
0sales
0purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Oct 21, 2025 to Oct 21, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
No open-market trade is on the record for these years.
Dollars as filed, summed by the transaction date.
People who traded in the window
No one on the roster filed an open-market trade in the window.